Des-Arg10-Kallidin Active Peptide

Lysyl-Des-Arg9-Bradykinin Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe (M.W. 1032.2) C50H73N13O11 [71800-36-7] Bradykinin B1-Receptor Selective Agonist J.P. Galizzi, M.C. Bodinier, B. Chapelain, S.M. Ly, L. Coussy, S. Giraud, G. Neliat, and T. Jean, Br. J. Pharmacol., 113, 389 (1994). (Original) J.G. Menke, J.A. Borkowski, K.K. Bierilo, T. MacNeil, A.W. Derrick, K.A. Schneck, R.W. Ransom, C.D. Strader, D.L. Linemeyer, and J.F. Hess,J. Biol. Chem., 269, 21583 (1994). (Pharmacol.) J.S. Zuzack, M.R. Burkard, D.K. Curdrado, R.A. Greer, W.M. Selig, and E.T. Whalley, J. Pharmacol. Exp. Ther., 277, 1337 (1996). Pharmacol.) E.G. Erdös (ed.) Bradykinin, Kallidin and Kallikrein, Handbook of Experimental Pharmacology, Vol. 25, Springer-Verlag, Berlin, 1970. (Review) E.G. Erdös (ed.) Bradykinin, Kallidin and Kallikrein, Handbook of Experimental Pharmacology, Vol. 25, Suppl., Springer-Verlag, Berlin, 1979. (Review)

Small volumes of Des-Arg10-Kallidin active peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS405430 is an active peptide targeting Des-Arg10-Kallidin.